SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Vion (formerly Oncorx) interesting play on Gene Therapy
An SI Board Since April 1996
Posts SubjectMarks Bans Symbol
370 14 0 VION
Emcee:  Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
320VION was UP 4.94% today to 3.61 on volume of 1.12 m. Market cap is 201.62 m with9wald9-2/1/2005
319Vion Pharma Gets Cure Period To Comply With Nasdaq Rule DOW JONES NEWSWIRES JanuJim Oravetz-1/28/2005
318In a January 6, 2005 press release, VION management stated that they intended to9wald9-1/12/2005
317Vion Pharmaceuticals Files $75M Mixed Sec Shelf DOW JONES NEWSWIRES December 14,Jim Oravetz-12/15/2004
316Vion To Begin PIII Trail For Cloretazine(Spring '05) + other news - tapet isJim Oravetz-9/24/2004
315VION Announces Initiation of a Phase II Trial Of CLORETAZINE (VNP40101M) In PatiJim Oravetz-6/2/2004
314Vion Reports 2004 First Quarter Financial Results NEW HAVEN, Conn., May 13 /PRNVIXandMore-5/13/2004
313vionpharm.com (EOM)Jim Oravetz-5/3/2004
312Vion Pharmaceuticals Registers 17.2M Shares For Holders DOW JONES NEWSWIRES MarcJim Oravetz-3/29/2004
311I don't believe that it is intended for that at all. EOMJim Oravetz-3/17/2004
310Does it have any applications in non terapeutic sun tanning?david-3/16/2004
309Vion Licenses Melasyn Rights DOW JONES NEWSWIRES Vion Pharmaceuticals Inc. (VIOJim Oravetz-3/15/2004
308Vion 4Q Loss 8c/Shr NEW HAVEN, Conn. -- Vion Pharmaceuticals Inc.'s (VION) Jim Oravetz-3/10/2004
307Vion Pharmaceuticals Inc. (VION) said the Food and Drug Administration had grantJim Oravetz-3/9/2004
306Vion Provides Update On Clinical Trials Of Triapine(R) As A Single Agent DOW JONJim Oravetz-2/6/2004
305Vion is breaking out on high volume, and not one post WAKE UP! PierrePierre Borczuk-1/31/2004
304vionpharm.comJim Oravetz-12/15/2003
303Vion Gets Initial Payment From Beijing Pason License Pact DOW JONES NEWSWIRES NJim Oravetz-11/12/2003
302Vion Licenses Triapine Rights In China, Taiwan, Hong Kong And Macao DOW JONES NEJim Oravetz-10/21/2003
301Vion And Lilly Enter Into Research Services Pact DOW JONES NEWSWIRES NEW HAVEN,Jim Oravetz-9/8/2003
300Vion Initiates Phase 1 Trial of VNP40101M and Ara-C NEW HAVEN, Conn., July 23 /Jim Oravetz-7/31/2003
299Vion Announces Termination Of Phase 1 TAPET(R) Trial DOW JONES NEWSWIRES NEW HAJim Oravetz-6/20/2003
298Vion Enters Into Agreements For $5 M Private Placement DOW JONES NEWSWIRES NEW Jim Oravetz-6/20/2003
297This one is just low on the radar. SI with its paid structure is not going to gJim Oravetz-6/3/2003
296Up 85%, and now a 10-bagger from the low. And silence.Sr K-6/2/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News